Connect to other sites within the UBM Medica Network
This article will discuss current tools, approaches, and concerns regarding patient care in this setting.
Commentary: Lung Cancer Screening: Has Its Time Come?
Higher Breath Temperature Could Signal Lung Cancer
Exhaled breath temperature higher than 34 degrees Celsius (93.2 degrees F) could serve as a cutoff value to help diagnose lung cancer, according to a new study.
Elderly Get Most Benefit, Harm From Lung Cancer Screening
A new analysis of the NLST showed that both the benefits and harms of low-dose CT screening are slightly greater among patients older than 65 years.
Best Methods for ALK Screening in Non–Small-Cell Lung Cancer
A new study sheds light on the prevalence of ALK positive non–small-cell lung cancer and suggests the best methods for screening.
ACR Appropriateness Criteria® Nonsurgical Treatment for Locally Advanced Non–Small-Cell Lung Cancer: Good Performance Status/Definitive Intent
The treatment of inoperable stage III non–small-cell lung cancer (NSCLC) remains a challenge due to high rates of distant metastasis, local recurrence, and toxicity associated with definitive therapy.
Trends in Lung Cancer Incidence
Overall lung cancer rates have declined in the United States, but a new study shows how certain subtypes and demographic groups have more complicated trajectories.
LDCT for Lung Cancer Screening: The Effect of False-Positives
Patients who underwent low-dose CT for lung cancer screening and received false-positives benefited from counseling.
Treatment Combo for EGFR Inhibitor-Resistant Lung Cancer
Combining the EGFR inhibitors afatinib and cetuximab resulted in clinical responses among advanced lung cancer patients who had previously stopped responding to monotherapy treatment with other EGFR inhibitors.
Oncogenic Drivers in Lung Cancer
From the 2014 ASCO Annual Meeting, this internationally renowned lung cancer expert discusses oncogenic driver mutations in lung cancer.
ASCO: Current and Upcoming Lung Cancer Research
Dr. Ramaswamy Govindan, Washington U at St. Louis, discusses patient screening, new research in targeted therapies, as well as the continued role of traditional chemotherapy in lung cancer.
ASCO: Controversies in the Treatment of Mesothelioma of the Pleura
In this exclusive video, Dr. Harvey Pass discusses surgery in mesothelioma of the pleura and other areas of disagreement.
ASCO: Chemotherapy Key Part of Curative Lung Cancer Therapies
As part of our coverage of the 2014 ASCO Annual Meeting, we discuss chemotherapy's curative role in treating lung cancer.
Combination Therapies for Lung Cancer
As part of our coverage of the AACR Annual Meeting, we discuss combination therapies and new research in the treatment of lung cancer.
Oncogenes Driving Squamous Cell Lung Carcinoma
In this interview we discuss the oncogenes driving the development of squamous cell carcinoma of the lung, a type of non-small-cell lung cancer.
Lung Cancer Prevention and Screening
In this interview we discuss lung cancer prevention, the recent low-dose CT screening recommendations from the USPSTF, hurdles in preventing the disease, and more.
By clicking Accept, you agree to become a member of the UBM Medica Community.